Trulieve Cannabis Corp.
TCNNF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 5.1% | -8.9% | 32.1% | – |
| Cost of Goods Sold | $0 | $1 | $1 | $0 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 60.3% | 52.1% | 55% | 60.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $0 |
| Operating Income | $0 | -$0 | $0 | $0 |
| % Margin | 8.2% | -19.6% | 8.8% | 21% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | -$0 | -$0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$1 | -$0 | $0 |
| % Margin | -13.1% | -46.7% | -16.5% | 1.9% |
| EPS | -0.82 | -2.84 | -1.1 | 0.13 |
| % Growth | 71.1% | -158.2% | -946.2% | – |
| EPS Diluted | -0.82 | -2.84 | -1.09 | 0.12 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | -$0 | $0 | $0 |
| % Margin | 21.8% | -2.9% | 19.3% | 30.2% |